Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
02/2006
02/01/2006EP1620089A1 Therapeutic and prophylactic compositions and uses therefor
02/01/2006EP1620082A2 Medical use of inhibitors of glutaminyl and glutamate cyclases
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
02/01/2006EP1194409B1 Pyrazolidinol compounds
02/01/2006CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2
01/2006
01/31/2006USRE38963 for treating a migraine, disorders associated with inflammation, menstrual disorders, respiratory disorders, gastrointestinal afflications, skin disorders
01/31/2006USRE38962 Diphenyl-triazole derivatives and their use as anti-gestative immuno-suppressant and anti-tumoral agents
01/31/2006US6992099 For controlling parasites in or on an animal
01/31/2006US6992098 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination
01/31/2006US6992097 such as methyl-1-{2-[4-((2R)-2-{2-[(tert-butoxy)carbonylamino]-2-methylpropanoylamino}-3-indol-3-ylpropanoylamino)imidazolyl]-2-phenylacetyl}pyrrolidine-2-carboxylate
01/31/2006CA2239081C Novel 5-amino-3-cyano-4-ethylsulfinyl-1-phenyl-pyrazole compounds and their use as pesticides
01/26/2006WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
01/26/2006WO2006009741A1 Kinase inhibitors
01/26/2006WO2005118552A3 Anthranilamide insecticides
01/26/2006US20060020013 Control of arthropods in animals
01/26/2006US20060020012 Pyrazole derivatives
01/26/2006US20060020010 Substituted pyrazoline compounds, their preparation and use as medicaments
01/26/2006US20060020003 Biphenyloxy-acids
01/26/2006US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases
01/26/2006US20060020000 N,N-Dibutyl-2-[3-(2,2-dimethylpropanoyl)-6-methoxy-1H-indazol-1-yl]acetamide; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, intraoccular pressure in the eye
01/26/2006US20060019997 Triazole compounds and their use as metabotropic glutamate receptor antagonists
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/26/2006CA2573109A1 Non-natural amino acids
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1618093A2 Indazole derivatives as jnk inhibitors
01/25/2006EP1618092A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
01/25/2006EP1618087A2 Antibacterial agents
01/25/2006EP1617840A2 Pyrazole-amide compounds useful as kinase inhibitors
01/25/2006EP1617806A2 Selective spirocyclic glucocorticoid receptor modulators
01/25/2006EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1
01/25/2006CN1726217A Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
01/24/2006US6989402 Thyroid receptor ligands and method II
01/24/2006US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
01/19/2006US20060014817 CCK-1 receptor modulators
01/19/2006US20060014816 such as: 3-{5-[3-(2-methoxyethoxy)-1-propynyl]-3-thienyl}-6-[(4-methyl-1-piperazinyl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole; diseases resulting from inappropriate activation of the immune system (e.g., autoimmune disorders), allograft rejection, and graft vs. host disease
01/19/2006US20060014815 Process for making pyrazole compounds
01/19/2006US20060014813 Pharmaceutical compounds that regenerate in vivo
01/19/2006US20060014808 Novel anthranilamide insecticides
01/19/2006US20060014794 CXCR1 and CXCR2 chemokine antagonists
01/19/2006US20060014783 Sulfonylamino-acetic acid derivatives
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/19/2006CA2571821A1 Prodrugs of mitotic kinesin inhibitors
01/18/2006EP1616867A1 Hydroxycarboxylic acid derivatives
01/18/2006EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
01/18/2006EP1616859A1 Substituted cyclohexyl carboxylic acid compounds
01/18/2006EP1615895A1 Biaryl substituted pyrazoles as sodium channel blockers
01/18/2006EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615698A2 New amide derivatives and pharmaceutical use thereof
01/18/2006EP1615636A1 Bicyclic compounds as nr2b receptor antagonists
01/18/2006EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
01/18/2006EP1417204B1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
01/18/2006EP1268096B1 Extrusion die
01/18/2006EP1213965B1 Thrombopoietin mimetics
01/18/2006EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
01/18/2006CN1723201A Blood-brain barrier disruption inhibitors
01/18/2006CN1237054C Insecticidal and acaricidal agents
01/18/2006CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/17/2006US6987112 Organic compound having cyano group and insecticides/miticides
01/12/2006WO2006003277A1 Aromatic biaryl products, compositions containing same and use as medicines
01/12/2006WO2006003276A1 Substituted indazoles, compositions containing same, preparation and use
01/12/2006WO2005080343A3 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
01/12/2006WO2005060959A8 Pyrazole derivatives and use thereof as orexin receptor antagonists
01/12/2006US20060009528 Cannabinoid receptor ligands
01/12/2006US20060009487 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
01/12/2006US20060008670 Organic light emitting materials and devices
01/12/2006US20060005320 N-alkylheteroaryl secondary para-phenylenediamine and composition comprising such a para-phenylenediamine
01/12/2006CA2571588A1 Pyrazolopyridine derivatives
01/12/2006CA2570320A1 .alpha.,.beta.-unsaturated esters and acids by stereoselective dehydration
01/12/2006CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity
01/12/2006CA2567744A1 Substituted indazoles, compositions containing same, preparation and use
01/12/2006CA2567020A1 Aromatic biaryl products, compositions containing same and use as medicines
01/11/2006EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
01/11/2006EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them
01/11/2006EP1613631A1 Pyrrolo 1,2-b pyridazine compounds and their uses
01/11/2006CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors
01/11/2006CN1720234A Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
01/11/2006CN1720233A Pesticidal sulphonylaminopyrazoles
01/11/2006CN1720046A 5-substituted 2h-pyrazone-3-carboxylic acid derivatives as antilipolytic agents for the treatment of metabolic-related disorders such as dyslipidemia
01/11/2006CN1719974A Pesticidal 5- (acylamino) pyrazole derivatives
01/10/2006CA2129897C Coa-it and paf inhibitors
01/05/2006WO2006000314A1 N-phenylpyrazole derivatives as pesticides
01/05/2006WO2006000313A1 N-phenylpyrazole derivatives as pesticides
01/05/2006WO2006000312A1 Pesticidal n-phenylpyrazole derivatives
01/05/2006WO2006000311A1 1-arylpyrazole derivatives pesticidal agents
01/05/2006WO2005099709A3 Bicyclic heterocycles useful as serine protease inhibitors
01/05/2006US20060004208 Reacting an optionally substituted acetophenone with succinic anhydride and an alkoxide base to form a 2-(3-carboxypropionyl)acetophenone, which may then be reacted with a phenylhydrazine, esterified and reacted with N-methylhydroxylamine to form diaryl-3-(ethylhydroxamic acid) pyrazolederivatives
01/05/2006US20060004069 Agent for preventing or treating neuropathy
01/05/2006US20060004062 Compounds for inhibiting insulin secretion and methods related thereto
01/05/2006US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents
01/04/2006EP1611136A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
01/04/2006EP1611122A1 Substituted pyrazole compounds
01/04/2006EP1611120A1 Novel methods for the treatment of inflammatory diseases
01/04/2006EP1611107A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
01/04/2006EP1611094A1 Pyrazole compounds
01/04/2006EP1611089A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer's disease
01/04/2006EP1611088A2 Hydroxamates as therapeutic agents
01/04/2006EP1610780A2 Cyclic protein tyrosine kinase inhibitors
01/04/2006EP1610779A1 3-oxo-1,3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors
01/04/2006EP1408035B1 Method of preparing derivatives of 1.5-diaryl-3-trifluoromethyl-delta2-pyrazolines that are racemic and enantiomerically pure
01/04/2006EP1363873A4 Peptide deformylase inhibitors